Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Mysterious Fever Claims Lives in Almora and Haridwar

Hicks launches all new Hicks DT-12 Digital Thermometer with memory, beeper

Ruchika Sharma25 July 2021 9:00 AM IST

New Delhi: Hicks, a well-established and highly respected household name synonymous with thermometers in India, has launched Hicks DT-12 Digital...

Central govt officials team in continuous dialogue with Pfizer, Moderna, JnJ on indemnity, other issues, Says Minister

Ruchika Sharma24 July 2021 5:12 PM IST

New Delhi: A team of central government officials is in continuous dialogue with foreign Covid vaccine manufactures like Pfizer, Moderna and Johnson...

AstraZeneca gets US nod for once-weekly diabetes drug Bydureon for kids

Ruchika Sharma24 July 2021 4:57 PM IST

The drug aims to help reduce blood sugar levels along with diet and exercise.

Healthtech Startup CURAPOD Raises Rs 20 Cr to Scale Wearable Pain Management Technology

Ayurveda doctor platform NirogStreet raises around Rs 18 crore in Series A funding

Ruchika Sharma24 July 2021 2:37 PM IST

New Delhi: Ayurveda doctor platform, NirogStreet on Thursday said it has raised USD 2.5 million (around Rs 18 crore) in Series A funding from...

Bharat Biotech to begin COVAXIN trial on 2-6 years age group next week

Ruchika Sharma24 July 2021 2:27 PM IST

New Delhi: As part of its COVID-19 vaccination trials for children, Bharat Biotech is likely to administer the second dose of Covaxin to children aged...

Intas Pharma, Meiji, Dong-A ST ink licensing agreement for biosimilar to Ustekinumab

Ruchika Sharma24 July 2021 9:00 AM IST

Ahmedabad: Intas Pharmaceuticals Ltd has announced that the company has entered into an exclusive license agreement with Meiji and Dong-A Socio...

Philips ventilator recall classified as most serious by USFDA

Ruchika Sharma23 July 2021 3:58 PM IST

New Delhi: The U.S. Food and Drug Administration on Thursday classified the recall of Philips' breathing devices and ventilators as Class 1, or...

Despite neurological illness reports, JnJ Covid-19 vaccine benefits outweigh risks: US CDC advisers

Ruchika Sharma23 July 2021 12:45 PM IST

New Delhi: Despite reports of a rare neurological disorder appearing in some people who have received Johnson & Johnson's COVID-19 vaccine, the...

Drugmaker Endo to pay USD 35 million to settle opoid claims by Tennessee counties

Ruchika Sharma23 July 2021 12:00 PM IST

New Delhi: Endo International Plc has agreed to pay $35 million to settle a lawsuit by Tennessee local governments and on behalf of a child...

COVID vaccine IP waiver not property snatch, says WHO

Ruchika Sharma23 July 2021 10:00 AM IST

Geneva: The World Health Organization on Wednesday sought to reassure pharmaceutical companies that a proposal to suspend patent rights on Covid-19...

Glenmark arm to invest Rs 600 crore to double capacity in 4 years

Ruchika Sharma23 July 2021 9:00 AM IST

Mumbai: IPO-bound bulk drug manufacturer Glenmark Life Sciences is on track to more than double its capacity over the next four years at a cumulative...

Zydus Cadila Saroglitazar Mg gets Orphan Drug Designation from EMA

Ruchika Sharma22 July 2021 3:17 PM IST

Saroglitazar Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gamma dual agonist.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok